Challenges and solutions for diabetes early career researchers in the COVID‐19 recovery: perspectives of the Diabetes UK innovators in diabetes

Matthew C. Gage; Deirdre Harrington; Gemma V. Brierley; Rachel M. Freathy; Brendan M. Gabriel; Rachel Gibson; Alison D. McNeilly; Claire L. Meek; Lee D. Roberts

doi:10.1111/dme.14698

Challenges and solutions for diabetes early career researchers in the COVID‐19 recovery: perspectives of the Diabetes UK innovators in diabetes

Matthew C. Gage, Deirdre Harrington, Gemma V. Brierley, Rachel M. Freathy, Brendan M. Gabriel, Rachel Gibson, Alison D. McNeilly, Claire L. Meek, Lee D. Roberts

Physical Activity And Health

Research output: Contribution to journal › Letter › peer-review

165 Downloads (Pure)

Abstract

The COVID-19 pandemic has put diabetes at the forefront of conversation. The prevalence of type 2 diabetes in the United Kingdom is high1 and has links to adverse COVID-19 outcomes.2 Research investigating the links between these two public health issues are moving at pace. However, the pandemic has seen early career researchers (ECRs) in diabetes face professional and personal challenges that have the potential to slow down or derail bourgeoning careers. These challenges are not unique to ECRs working in the diabetes field—and they compound a challenging decade that included the fallout from an economic crisis and uncertainties arising from a protracted Brexit.

In May 2021, 15 ECRs gathered online as part of the Diabetes UK annual Innovators in Diabetes (IDia) training programme. A discussion on the career challenges faced and possible solutions to facilitate a healthy future for diabetes ECRs was initiated and facilitated by senior leaders in diabetes research. This letter summarises the themes from that discussion.

Original language	English
Article number	e14698
Journal	Diabetic Medicine
Volume	39
Issue number	3
Early online date	25 Sept 2021
DOIs	https://doi.org/10.1111/dme.14698
Publication status	E-pub ahead of print - 25 Sept 2021

Keywords

endocrinology
endocrinology, diabetes and metabolism
internal medicine

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1111/dme.14698

Gio-etal-PDS-ICED-2021-Control-of-a-drone-with-bodyAccepted author manuscript, 835 KB

Diabetes UK Innovators in Diabetes (IDia)
Harrington, D. (Participant)
1 Nov 2021 → 3 Nov 2021
Activity: Participating in or organising an event types › Participation in workshop, seminar, course

Cite this

Gage, M. C., Harrington, D., Brierley, G. V., Freathy, R. M., Gabriel, B. M., Gibson, R., McNeilly, A. D., Meek, C. L., & Roberts, L. D. (2021). Challenges and solutions for diabetes early career researchers in the COVID‐19 recovery: perspectives of the Diabetes UK innovators in diabetes. Diabetic Medicine, 39(3), Article e14698. Advance online publication. https://doi.org/10.1111/dme.14698

@article{9d113e7b2a03480d8b9af6c47569a320,

title = "Challenges and solutions for diabetes early career researchers in the COVID‐19 recovery: perspectives of the Diabetes UK innovators in diabetes",

abstract = "The COVID-19 pandemic has put diabetes at the forefront of conversation. The prevalence of type 2 diabetes in the United Kingdom is high1 and has links to adverse COVID-19 outcomes.2 Research investigating the links between these two public health issues are moving at pace. However, the pandemic has seen early career researchers (ECRs) in diabetes face professional and personal challenges that have the potential to slow down or derail bourgeoning careers. These challenges are not unique to ECRs working in the diabetes field—and they compound a challenging decade that included the fallout from an economic crisis and uncertainties arising from a protracted Brexit.In May 2021, 15 ECRs gathered online as part of the Diabetes UK annual Innovators in Diabetes (IDia) training programme. A discussion on the career challenges faced and possible solutions to facilitate a healthy future for diabetes ECRs was initiated and facilitated by senior leaders in diabetes research. This letter summarises the themes from that discussion.",

keywords = "endocrinology, endocrinology, diabetes and metabolism, internal medicine",

author = "Gage, {Matthew C.} and Deirdre Harrington and Brierley, {Gemma V.} and Freathy, {Rachel M.} and Gabriel, {Brendan M.} and Rachel Gibson and McNeilly, {Alison D.} and Meek, {Claire L.} and Roberts, {Lee D.}",

year = "2021",

month = sep,

day = "25",

doi = "10.1111/dme.14698",

language = "English",

volume = "39",

journal = "Diabetic Medicine",

issn = "0742-3071",

number = "3",

}

TY - JOUR

T1 - Challenges and solutions for diabetes early career researchers in the COVID‐19 recovery

T2 - perspectives of the Diabetes UK innovators in diabetes

AU - Gage, Matthew C.

AU - Harrington, Deirdre

AU - Brierley, Gemma V.

AU - Freathy, Rachel M.

AU - Gabriel, Brendan M.

AU - Gibson, Rachel

AU - McNeilly, Alison D.

AU - Meek, Claire L.

AU - Roberts, Lee D.

PY - 2021/9/25

Y1 - 2021/9/25

N2 - The COVID-19 pandemic has put diabetes at the forefront of conversation. The prevalence of type 2 diabetes in the United Kingdom is high1 and has links to adverse COVID-19 outcomes.2 Research investigating the links between these two public health issues are moving at pace. However, the pandemic has seen early career researchers (ECRs) in diabetes face professional and personal challenges that have the potential to slow down or derail bourgeoning careers. These challenges are not unique to ECRs working in the diabetes field—and they compound a challenging decade that included the fallout from an economic crisis and uncertainties arising from a protracted Brexit.In May 2021, 15 ECRs gathered online as part of the Diabetes UK annual Innovators in Diabetes (IDia) training programme. A discussion on the career challenges faced and possible solutions to facilitate a healthy future for diabetes ECRs was initiated and facilitated by senior leaders in diabetes research. This letter summarises the themes from that discussion.

AB - The COVID-19 pandemic has put diabetes at the forefront of conversation. The prevalence of type 2 diabetes in the United Kingdom is high1 and has links to adverse COVID-19 outcomes.2 Research investigating the links between these two public health issues are moving at pace. However, the pandemic has seen early career researchers (ECRs) in diabetes face professional and personal challenges that have the potential to slow down or derail bourgeoning careers. These challenges are not unique to ECRs working in the diabetes field—and they compound a challenging decade that included the fallout from an economic crisis and uncertainties arising from a protracted Brexit.In May 2021, 15 ECRs gathered online as part of the Diabetes UK annual Innovators in Diabetes (IDia) training programme. A discussion on the career challenges faced and possible solutions to facilitate a healthy future for diabetes ECRs was initiated and facilitated by senior leaders in diabetes research. This letter summarises the themes from that discussion.

KW - endocrinology

KW - endocrinology, diabetes and metabolism

KW - internal medicine

U2 - 10.1111/dme.14698

DO - 10.1111/dme.14698

M3 - Letter

SN - 0742-3071

VL - 39

JO - Diabetic Medicine

JF - Diabetic Medicine

IS - 3

M1 - e14698

ER -

Challenges and solutions for diabetes early career researchers in the COVID‐19 recovery: perspectives of the Diabetes UK innovators in diabetes

Abstract

Keywords

UN SDGs

Access to Document

Fingerprint

Activities

Diabetes UK Innovators in Diabetes (IDia)

Cite this